Ophthalmic Viscosurgical Devices

Global Ophthalmic Viscosurgical Devices Market to Reach US$564.3 Million by 2030

The global market for Ophthalmic Viscosurgical Devices estimated at US$429.8 Million in the year 2024, is expected to reach US$564.3 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Dispersive Ophthalmic Viscosurgical Devices, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$293.8 Million by the end of the analysis period. Growth in the Cohesive Ophthalmic Viscosurgical Devices segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$117.1 Million While China is Forecast to Grow at 7.2% CAGR

The Ophthalmic Viscosurgical Devices market in the U.S. is estimated at US$117.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$109.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Ophthalmic Viscosurgical Devices Market – Key Trends & Drivers Summarized

Why Are Viscosurgical Devices Indispensable in Modern Ocular Surgery?

Ophthalmic Viscosurgical Devices (OVDs) have established themselves as a cornerstone in ocular surgeries, particularly cataract procedures, by offering critical intraoperative support. These gel-like substances, typically composed of sodium hyaluronate or other viscoelastic compounds, are essential in maintaining anterior chamber stability, protecting intraocular tissues, and facilitating intraocular lens (IOL) implantation. With cataract surgery being one of the most frequently performed procedures worldwide, the demand for reliable and high-performing OVDs continues to grow in parallel. Their role is even more vital in complex surgeries such as glaucoma filtering procedures, corneal transplants, and vitreoretinal interventions, where tissue protection and space maintenance are critical. As surgical techniques evolve toward micro-incisional and femtosecond laser-assisted procedures, the reliance on high-purity, phase-specific OVDs is increasing. This trend is reinforced by the rising geriatric population globally, which presents a larger pool of patients requiring age-related eye care interventions. Moreover, the consistent emphasis on post-operative outcomes and patient safety is pushing surgeons to adopt advanced OVDs that reduce endothelial damage and inflammation. Thus, these devices are not only essential from a surgical standpoint but are also becoming increasingly integrated into protocols focused on improving visual outcomes and recovery profiles.

How Is Product Innovation Elevating the Performance of OVDs?

Innovation in ophthalmic viscosurgical devices is reshaping surgical precision, safety, and efficiency. One of the most significant advancements is the development of dual-function OVDs—also known as dispersive-cohesive combinations—which offer the benefits of both space maintenance and tissue protection in a single application. These formulations simplify the surgical process and reduce the need for multiple product administrations. Manufacturers are also refining the molecular structure of viscoelastics to improve flow dynamics, increase transparency, and enhance retention within the anterior chamber. These improvements allow for better manipulation of ocular structures during phacoemulsification and IOL placement, particularly in complex cases such as small pupil or floppy iris syndrome. Additionally, pre-filled syringes and ergonomic delivery systems are being introduced to improve handling and minimize waste during procedures. Advances in cross-linked hyaluronic acid formulations are contributing to prolonged retention and better viscoelastic behavior under stress, aligning with the needs of modern, high-speed surgical techniques. Biocompatibility remains a major focus area, with innovations aiming to further reduce the risk of inflammation, IOP spikes, and post-op complications. Furthermore, research is ongoing into biodegradable and drug-eluting OVDs that could provide both mechanical and pharmacological benefits intraoperatively. These technological strides are not only boosting surgical outcomes but are also creating differentiation in a competitive market landscape.

What End-Use and Geographic Trends Are Defining Demand Patterns?

Demand for ophthalmic viscosurgical devices is being strongly influenced by both end-user preferences and regional healthcare developments. In high-income countries, where surgical infrastructure is advanced and patient expectations are high, ophthalmic surgeons increasingly prefer premium OVDs that offer enhanced performance and safety. The presence of well-established ophthalmology centers and high surgical throughput in countries like the U.S., Germany, and Japan ensures steady consumption of high-grade, branded OVDs. In contrast, emerging markets such as India, Brazil, and parts of Southeast Asia are witnessing rapid adoption driven by rising cataract surgery volumes, improved healthcare access, and government-backed blindness prevention initiatives. In these regions, cost-effective yet reliable OVDs are in demand to support high-volume eye care programs and mobile surgical camps. The increasing number of ambulatory surgical centers and standalone eye clinics is also expanding the buyer base for single-use, pre-sterilized OVDs that enable fast turnover and reduce the risk of contamination. Academic institutions and surgical training centers further contribute to demand as they incorporate OVD use into standardized surgical education protocols. Additionally, the rise of private equity-backed ophthalmology chains and franchised vision care networks is leading to centralized procurement and standardization of OVD brands, increasing market visibility for leading manufacturers. These trends underscore a clear shift toward more strategic and volume-driven purchasing behavior across different market tiers.

What Key Forces Are Fueling Growth in the Ophthalmic Viscosurgical Devices Market?

The growth in the ophthalmic viscosurgical devices market is driven by several factors related to technological refinement, surgical volume expansion, and shifts in clinical practice standards. One of the primary growth drivers is the global increase in cataract surgeries, supported by rising life expectancy and growing awareness of early vision restoration options. The transition toward minimally invasive and laser-assisted surgical techniques is increasing demand for OVDs that offer enhanced retention, clarity, and chamber stability under rapid intraoperative conditions. End-user demand for single-use, sterile, and pre-filled OVD formats is also growing, especially in ambulatory and high-throughput surgical centers. Continued product innovation, including dual-phase and viscoadaptive OVDs, is expanding clinical utility across a broader range of surgical scenarios, from standard lens implantation to advanced anterior and posterior segment procedures. In emerging markets, the expansion of vision care access through public health programs, non-governmental initiatives, and mobile surgical units is driving significant volumes of OVD consumption. Additionally, strategic collaborations between ophthalmic equipment manufacturers and pharmaceutical companies are enhancing product bundling and integrated surgical offerings. The growing penetration of training programs and simulation-based education in ophthalmology is increasing practitioner familiarity and confidence with advanced OVD usage. These combined factors are positioning ophthalmic viscosurgical devices as a critical and growing component within the broader landscape of global eye care.

SCOPE OF STUDY:

The report analyzes the Ophthalmic Viscosurgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices, Viscoadaptive Ophthalmic Viscosurgical Devices); Source (Biological Source, Animal Source, Semi-Synthetic Source); Application (Cataract Surgery Application, Corneal Grafting Application, Glaucoma Surgery Application, Vitreoretinal Grafting Application)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• Advin Health Care
• Alcon Inc.
• Altacor Limited
• Amring Pharmaceuticals Inc.
• Bausch & Lomb Incorporated
• Beaver-Visitec International Inc.
• Bloomage Biotechnology Corporation Limited
• Bohus Biotech AB
• Carl Zeiss Meditec AG
• CIMA Technology Inc.
• Eyebright Medical Technology Co., Ltd.
• Eyekon Medical Inc.
• Haohai Biological Technology
• Johnson & Johnson Surgical Vision, Inc.
• Maxigen Biotech Inc.
• Ophtechnics Unlimited
• Rayner Intraocular Lenses Limited
• RUMEX International Co.
• Santen Pharmaceutical Co., Ltd.
• Truviz Ophthalmic

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.